The aim of the present study was to determine the frequency of germline copy number changes of TP53BRCA1, and BRCA2 genes in breast cancer patients with clinical diagnosis of Li-Fraumeni or Li-Fraumeni-like syndrome, and without detectable germline TP53 point mutations. The gene discussed is BRCA2; the disease is breast carcinoma.